ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2

BACKGROUND: High-Flow Nasal Cannula (HFNC) therapy is useful treatment in patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction of inspired oxygen to respiratory rate) has been evaluated to predict success of HFNC in patients with pneumonia. OBJECTIVE: The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer, Santos, Sancho, Jesús, Bocigas, Irene, Bures, Enric, Mora, Heidi, Monclou, Erik, Mulet, Alba, Quezada, Antonio, Royo, Pablo, Signes-Costa, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492361/
https://www.ncbi.nlm.nih.gov/pubmed/34634500
http://dx.doi.org/10.1016/j.rmed.2021.106638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492361/
https://www.ncbi.nlm.nih.gov/pubmed/34634500
http://dx.doi.org/10.1016/j.rmed.2021.106638

Ejemplares similares